Business · 16/08/2011

FDA Releases Draft Guidance for Handling Postmarket Surveillance Studies for Device Manufacturers

The FDA has made available a draft guidance document to assist device manufacturers in fulfilling their postmarket surveillance obligations under Section 522 of the Federal Food, Drug, and Cosmetic Act, providing an overview of the law, procedural information, and submission guidelines.